122 related articles for article (PubMed ID: 37939515)
1. The blockage signal for PD-L1/CD274 gene variants and their potential impact on lung carcinoma susceptibility.
Sakran MI; Alalawy AI; Alharbi AA; El-Hefnawy ME; Alzahrani SM; Alfuraydi A; Alzuaibr FM; Zidan NS; Elsaid AM; Toraih EA; Elshazli RM
Int Immunopharmacol; 2023 Dec; 125(Pt A):111180. PubMed ID: 37939515
[TBL] [Abstract][Full Text] [Related]
2. Common inherited variants of PDCD1, CD274 and HAVCR2 genes differentially modulate the risk and prognosis of adenocarcinoma and squamous cell carcinoma.
Moksud N; Wagner M; Pawełczyk K; Porębska I; Muszczyńska-Bernhard B; Kowal A; Wiśniewski A; Kosacka M; Kończak J; Karpiński P; Frydryk D; Andrzejczak A; Karabon L; Kuśnierczyk P; Jasek M
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6381-6390. PubMed ID: 36759392
[TBL] [Abstract][Full Text] [Related]
3. Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population.
Xie Q; Chen Z; Xia L; Zhao Q; Yu H; Yang Z
Gene; 2018 Oct; 674():188-194. PubMed ID: 29940275
[TBL] [Abstract][Full Text] [Related]
4. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the Possible Association between PD-1 (Rs11568821, Rs2227981, Rs2227982) and PD-L1 (Rs4143815, Rs2890658) Polymorphisms and Susceptibility to Breast Cancer in a Sample of Southeast Iranian Women.
Karami S; Sattarifard H; Kiumarsi M; Sarabandi S; Taheri M; Hashemi M; Bahari G; Ghavami S
Asian Pac J Cancer Prev; 2020 Oct; 21(10):3115-3123. PubMed ID: 33112575
[TBL] [Abstract][Full Text] [Related]
6. Programmed death-ligand 1 (PD-L1) polymorphisms as predictive biomarkers for the development of liver cirrhosis and hepatocellular carcinoma in HCV Egyptian patients.
Hassan M; Attia MS; Ali-Eldin Z; El Attar G; Elzallat M; Saad HHK; Isaac A
Tumour Virus Res; 2022 Dec; 14():200249. PubMed ID: 36265835
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of the PD-L1 gene 3'-untranslated region are associated with the expression of PD-L1 in non-small cell lung cancer.
Ohhara Y; Tomaru U; Kinoshita I; Hatanaka KC; Noguchi T; Hatanaka Y; Amono T; Matsuno Y; Dosaka-Akita H
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23216. PubMed ID: 38169142
[TBL] [Abstract][Full Text] [Related]
8. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of the programmed death-ligand 1 gene is associated with its protein expression and prognosis in gastric cancer.
Wu Y; Zhao T; Jia Z; Cao D; Cao X; Pan Y; Zhao D; Zhang B; Jiang J
J Gastroenterol Hepatol; 2019 Jul; 34(7):1201-1207. PubMed ID: 30353572
[TBL] [Abstract][Full Text] [Related]
10. rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC.
Polcaro G; Liguori L; Manzo V; Chianese A; Donadio G; Caputo A; Scognamiglio G; Dell'Annunziata F; Langella M; Corbi G; Ottaiano A; Cascella M; Perri F; De Marco M; Col JD; Nassa G; Giurato G; Zeppa P; Filippelli A; Franci G; Piaz FD; Conti V; Pepe S; Sabbatino F
Mol Cancer; 2024 Mar; 23(1):63. PubMed ID: 38528526
[TBL] [Abstract][Full Text] [Related]
11. Association of PD-L1 gene rs4143815 C>G polymorphism and human cancer susceptibility: A systematic review and meta-analysis.
Zou J; Wu D; Li T; Wang X; Liu Y; Tan S
Pathol Res Pract; 2019 Feb; 215(2):229-234. PubMed ID: 30552042
[TBL] [Abstract][Full Text] [Related]
12. Immunogenetic polymorphisms predict therapeutic efficacy and survival outcomes in tumor patients receiving PD-1/PD-L1 blockade.
Xin Z; You L; Li J; Na F; Chen M; Song J; Bai L; Chen H; Zhai J; Zhou X; Zhou J; Ying B
Int Immunopharmacol; 2023 Aug; 121():110469. PubMed ID: 37311357
[TBL] [Abstract][Full Text] [Related]
13. Associations of PD-1 and PD-L1 gene polymorphisms with cancer risk: a meta-analysis based on 50 studies.
Yang M; Liu Y; Zheng S; Geng P; He T; Lu L; Feng Y; Jiang Q
Aging (Albany NY); 2024 Mar; 16(7):6068-6097. PubMed ID: 38546391
[TBL] [Abstract][Full Text] [Related]
14. Impact of PD-L1 Gene Polymorphisms and Interactions with Cooking with Solid Fuel Exposure on Tuberculosis.
Tang K; Wang J; Zhong H; Wang Q; Li Z; Wu C; An R; Lin Y; Tan H; Chen L; Wang M; Chen M
Public Health Genomics; 2024; 27(1):74-82. PubMed ID: 38735285
[TBL] [Abstract][Full Text] [Related]
15. Elevated programmed cell death-1 protein/ligand (PD-1/PD-L1) and variants are associated with susceptibility to multiple myeloma: a case-control study in the Chinese cohort.
Yang J; Meng L; Yang Y; Gao H; Jiang H
Nucleosides Nucleotides Nucleic Acids; 2024; 43(3):230-248. PubMed ID: 37688463
[TBL] [Abstract][Full Text] [Related]
16. Genomic data from NSCLC tumors reveals correlation between SHP-2 activity and PD-L1 expression and suggests synergy in combining SHP-2 and PD-1/PD-L1 inhibitors.
Toral KJ; Wuenschel MA; Black EP
PLoS One; 2021; 16(8):e0256416. PubMed ID: 34437586
[TBL] [Abstract][Full Text] [Related]
17. Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer.
Tan D; Sheng L; Yi QH
Cancer Biomark; 2018 Feb; 21(2):287-297. PubMed ID: 29171986
[TBL] [Abstract][Full Text] [Related]
18. Counter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interaction.
Shi XL; Mancham S; Hansen BE; de Knegt RJ; de Jonge J; van der Laan LJ; Rivadeneira F; Metselaar HJ; Kwekkeboom J
J Hepatol; 2016 Jun; 64(6):1274-82. PubMed ID: 26941095
[TBL] [Abstract][Full Text] [Related]
19. MAPK pathway activity plays a key role in PD-L1 expression of lung adenocarcinoma cells.
Stutvoet TS; Kol A; de Vries EG; de Bruyn M; Fehrmann RS; Terwisscha van Scheltinga AG; de Jong S
J Pathol; 2019 Sep; 249(1):52-64. PubMed ID: 30972766
[TBL] [Abstract][Full Text] [Related]
20. Association of PD-1 and PD-L1 Genetic Polymorphyisms with Type 1 Diabetes Susceptibility.
Qian C; Guo H; Chen X; Shi A; Li S; Wang X; Pan J; Fang C
J Diabetes Res; 2018; 2018():1614683. PubMed ID: 30534571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]